Transfer of the chemokine receptor CCR5 between cells by membrane- derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection

Nature Medicine

Volumn 6, Issue 7, 2000, Pages 769-775

  Mack, Matthias ^a   Kleinschmidt, Andrea ^b   Brühl, Hilke ^a   Klier, Christiane ^a   Nelson, Peter J ^a   Cihak, Josef ^c   Plachý, Jiří ^d   Stangassinger, Manfred ^c   Erfle, Volker ^b   Schlöndorff, Detlef ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYTOCHALASIN D;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL MIGRATION; CELL TRANSFER; CHO CELL; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; MACROPHAGE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION; RECEPTOR INTRINSIC ACTIVITY;

ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CHEMOTAXIS, LEUKOCYTE; CHO CELLS; CRICETINAE; ENDOTHELIUM, VASCULAR; HIV-1; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; RECEPTORS, CCR5;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033929004     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/77498     Document Type: Article

References (45)

1. Berger, E.A., Murphy, P.M. & Farber, J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700 (1999).
2. Samson, M. et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725 (1996).
3. Edinger, A.L. et al. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc. Natl. Acad. Sci. USA 94, 14742-7 (1997).
4. Wiley, C.A., Schrier, R.D., Nelson, J.A., Lampert, P.W. & Oldstone, M.B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83, 7089-7093 (1986).
5. Nuovo, C.J., Gallery, F., MacConnell, P. & Braun, A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am. J. Pathol. 144, 659-666 (1994).
6. Bagasra, O. et al. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 10, 573-585 (1996).
7. Ray, P.E. et al. Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int. 53, 1217-1229 (1998).
8. Schrager, L.K. & D'Souza, M.P. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. J. Am. Med. Assoc. 280, 67-71 (1998).
9. Brack-Werner, R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13, 1-22 (1999).
10. Rottman, J.B. et al. Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection. Am. J. Pathol. 151, 1341-1351 (1997).
11. Segerer, S., Mack, M., Regele, H., Kerjaschki, D. & Schlondorff, D. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int. 56, 52-64 (1999).
12. Sabri, F. et al. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology 264, 370-384 (1999).
13. Klein, R.S. et al. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J. Immunol. 163, 1636-1646 (1999).
14. Armstrong, M.J., Storch, J. & Dainiak, N. Structurally distinct plasma membrane regions give rise to extracellular membrane vesicles in normal and transformed lymphocytes. Biochim. Biophys. Acta. 946, 106-112 (1988).
15. Beaudoin, A.R. & Grondin, G. Shedding of vesicular material from the cell surface of eukaryotic cells: different cellular phenomena. Biochim. Biophys. Acta. 1071, 203-219 (1991).
16. Zwaal, R.F. & Schroit, A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89, 1121-1132 (1997).
17. Combes, V. et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 104, 93-102 (1999).
18. George, J.N., Thoi, L.L., McManus, L.M. & Reimann, T.A. Isolation of human platelet membrane micropartides from plasma and serum. Blood 60, 834-840 (1982).
19. Barry, O.P., Pratico, D., Lawson, J.A. & FitzGerald, G.A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet micropartides. J. Clin. Invest. 99, 2118-2127 (1997).
20. Barry, O.P., Pratico, D., Savani, R.C. & FitzGerald, G.A. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J. Clin. Invest. 102, 136-144 (1998).
21. Raposo, G. et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161-1172 (1996).
22. Zitvogel, L. et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nature Med. 4, 594-600 (1998).
23. Mesri, M. & Altieri, D.C. Endothelial cell activation by leukocyte microparticles. J. Immunol. 161, 4382-4387 (1998).
24. Mallat, Z. et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99, 348-353 (1999).
25. Mallat, Z. et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 101, 841-843 (2000).
26. Gluschankof, P., Mondor, I., Gelderblom, H.R. & Sattentau, Q.J. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 210, 125-133 (1997).
27. Xiao, X. et al. Constitutive cell surface association between CD4 and CCR5. Proc. Natl. Acad. Sci. USA 96, 7496-7501 (1999).
28. Mack, M. et al. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J. Exp. Med. 187, 1215-1224 (1998).
29. Levene, R.B. & Rabellino, E.M. Platelet glycoproteins IIb and IIIa associated with blood monocytes are derived from platelets. Blood 67, 207-213 (1986).
30. Satta, N. et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J. Immunol. 153, 3245-3255 (1994).
31. Speck, R.F. et al. A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1. Curr. Biol. 9, 547-550 (1999).
32. Gosling, J. et al. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94, 5061-5066 (1997).
33. Alkhatib, C., Locati, M., Kennedy, P.E., Murphy, P.M. & Berger, E.A. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 234, 340-348 (1997).
34. Farzan, M. et al. HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272, 6854-6857 (1997).
35. Marechal, V., Clavel, F., Heard, J.M. & Schwartz, O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J. Virol. 72, 2208-2212 (1998).
36. Wiley, C.A. & Achim, C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36, 673-676 (1994).
37. Conant, K. et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc. Natl. Acad. Sci. USA 95, 3117-3121 (1998).
38. Ostrowski, M.A. et al. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J. Immunol. 161, 3195-3201 (1998).
39. de Roda Husman, A.M., Blaak, H., Brouwer, M. & Schuitemaker, H. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection. J. Immunol. 163, 4597-4603 (1999).
40. Fritsch, L. et al. Production of HIV-1 by human B cells infected in vitro: characterization of an EBV genome-negative B cell line chronically synthetizing a low level of HIV-1 after infection. Virology 244, 542-551 (1998).
41. Lopalco, L. et al. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro. J. Immunol. 164, 3426-3433 (2000).
42. Oppermann, M., Mack, M., Proudfoot, A.E. & Olbrich, H. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J. Biol. Chem. 274, 8875-8885 (1999)
43. Rieber, E.P. et al The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis. Proc. Natl. Acad. Sci. USA 89, 10792-10796 (1992).
44. Rubsamen-Waigmann, H., Willems, W.R., Bertram, U. & von Briesen, H. Reversal of HIV-phenotype to fulminant replication on macrophages in perinatal transmission. Lancet 2, 1155-1156 (1989).
45. Popovic, M, Sarngadharan, M.C., Read, E. & Gallo, R.C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224, 497-500 (1984).